PFE Stock Recent News

Investors and now Wall Street love dividend stocks, especially the high-yield variety, because they offer a significant income stream and have massive total return potential.

Since May 2017, reader-selected dividend-paying stocks have been featured, with valuable reader feedback improving accuracy and direction. My Dogs of The Week portfolios are available for Dividend Dogcatcher subscribers, with detailed summaries and reference guides listed by date. I prioritize stocks whose dividends from $1K invested exceed their single share price, categorizing them as "cash rich" or "cash poor".

Pfizer divests its 7.3% remaining stake in Haleon to institutional investors and Haleon itself.

If you're looking for reasonably priced stocks to pick up right now, you shouldn't overlook Pfizer (PFE -0.50%). The pharmaceutical giant isn't as risky an investment as it may appear to be.

Healthcare is a defensive sector that is more resilient to economic downturns than most others. That's one of several reasons it is home to solid dividend stocks, including Pfizer (PFE -0.49%) and Bristol Myers Squibb (BMY 0.23%), two of the leading pharmaceutical companies in the world.

Uncertainty dominates the market, with consumer sentiment and business confidence at multi-year lows. Inflation fears persist, and policy support seems unlikely. Amid rising risks, I favor high-yield stocks with strong business models. These picks offer stability, solid dividends, and long-term market-beating potential. My selections span key sectors, ensuring steady income and growth. Each stock is attractively valued, making them compelling opportunities in today's volatile market.

Investor enthusiasm hit a fever pitch following the 2024 election, but took a punch to the gut recently. Market indexes have been falling as investors are beginning to assume President Trump will make good on repeated promises to raise the cost of goods entering the U.S. from the country's largest trading partners through tariffs.

Pfizer (PFE) closed at $26.21 in the latest trading session, marking a -0.38% move from the prior day.

I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the ten top-ranked stocks for consideration. I use two valuation screens, one based on my fair value estimate, and another comparing each stock's forward dividend yield with its 5-year average dividend yield. To rank stocks, I do a quality assessment and sort candidates by quality scores, breaking ties with additional metrics.

You'll need passive income to live well in retirement, especially with Social Security's uncertain future. The Office of Retirement and Disability Policy says Social Security's funds might run out by 2037, which could cut benefits to about 76% of what people get now.